跳至主要内容
临床试验/CTRI/2013/02/003410
CTRI/2013/02/003410尚未招募3 期

A Randomized controlled study to evaluate accelerated fractionation with standard best practice in Head and Neck cancers (Concurrent chemoradiation)

ICMR concept of proposal accepted0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a. Informed consent
  • b.Karnofsky performance scale between 70-100
  • c. Histologic proof of squamous cell carcinoma of larynx, oropharynx or hypopharynx, that is treatment naïve.
  • d.Stage IIâ??IVA.
  • e.No evidence of distant metastases {Chest X ray, USG abdomen or PETCT(optional).
  • f. a. No prior radiation treatment to the head and neck or any prior chemotherapy.

排除标准

  • a.Synchronous malignancy
  • b. Comobid condition like acute infections, chronic diseases such as renal, heart, liver (except Diabetes, Hypertension or Asthma).
  • c.Any condition that in the Investigators opinion may impact the safety of the procedure.

研究者

发起方
ICMR concept of proposal accepted

相似试验